FDA Inspection
Overton Brooks VA Medical CenterOverton Brooks VA Medical Center – FDA Inspection, Dec 18, 2024
Record Details
This FDA Inspection record concerns Overton Brooks VA Medical Center, with an inspection on December 18, 2024, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · ca9bc93d-9604-4ea4-838a-8018260747e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1257010
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- FD&C Act 501(a)(2)(A)Media fills, failure
- FD&C Act 501(a)(2)(A)Beta-lactam, hazardous, highly potent drugs, prevention of cross-contamination
- FD&C Act 501(a)(2)(A)Personnel infrequently, changed/sanitized gloves
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Overton Brooks VA Medical Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Overton Brooks VA Medical Center
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.